Co-regulator recruitment and the mechanism of retinoic acid receptor synergy

Nature

Volumn 415, Issue 6868, 2002, Pages 187-192

  Germain, Pierre ^a   Iyer, Jaya ^a,b   Zechel, Christina ^a,c   Gronemeyer, Hinrich ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b Monsanto Enterprises Pvt Ltd #277   (India)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATIONS; CRYSTAL STRUCTURE; MOLECULAR BIOLOGY; PROTEINS;

TRANSCONFORMATIONS;

CARBOXYLIC ACIDS;

CELL NUCLEUS RECEPTOR; DIMER; PROTEIN P160; RECEPTOR BLOCKING AGENT; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

BIOLOGY;

AGONIST; ARTICLE; BINDING SITE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

DIMERIZATION; DNA-BINDING PROTEINS; LIGANDS; MODELS, CHEMICAL; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; RETINOID X RECEPTORS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS;

EID: 0037050017     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/415187a     Document Type: Letter

References (30)

1. Nuclear receptor ligand-binding domains: Three-dimensional structures, molecular interactions and pharmacological implications
2. The coregulator exchange in transcriptional functions of nuclear receptors
3. Increasing the complexity ofcoactivation in nuclear receptor signaling
4. Regulation of retincid signalling by receptor polarity and allosteric control of ligand binding
5. Unique response pathways are established by allosteric interactions among nuclear hormone receptors
6. Two distinct actions of retinoid-receptor ligands
7. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers
8. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RARα)-, RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand
9. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways
10. Retinoids selective for retinoid X receptor response pathways
11. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF- 2 of nuclear receptors
12. Interactions controlling the assembly of nuclear-receptor heterodimers and coactivators
13. Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists
14. A transcriptional co-repressor that interacts with nuclear hormone receptors
15. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors
16. Mechanism of corepressor binding and release from nuclear hormone receptors
17. Molecular determinants of nuclear receptor-corepressor interaction
18. Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors
19. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains
20. Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors
21. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains
22. Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators
23. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins
24. Synergy between estrogen receptor a activation functions AF 1 and AF2 mediated by transcription intermediary factor TIF2
25. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription
26. 20-Epi analogues of 1, 25-dihydroxyvitamin D 3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor
27. RARs and RXRs: Evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo
28. Versatile copurification procedure for rapid isolation of homogeneous RAR-RXR heterodimers
29. Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: Purification, crystallization, and preliminary X-ray diffraction analysis
30. RAR-specific agonist antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation